O43526 (KCNQ2_HUMAN) Homo sapiens (Human)
Potassium voltage-gated channel subfamily KQT member 2 UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
18 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| human KCNQ2-CaM in complex with retigabine |
Heteromer P0DP25; | 4×FBX; | ||||
| Assess | ||||||
| Human KCNQ2(F104A)-CaM-PIP2-CBD complex in state II |
Heteromer P0DP23; | 4×P0T; 4×PIO; | ||||
| Assess | ||||||
| human KCNQ2-CaM in complex with PIP2 and HN37 |
Heteromer P0DP23; | 4×9MF; 4×PIO; | ||||
| Assess | ||||||
| Human KCNQ2-CaM in complex with CBD and PIP2 |
Heteromer P0DP23; | 8×P0T; 4×PIO; | ||||
| Assess | ||||||
| human KCNQ2-CaM-Ebio1 complex in the presence of PIP2 |
Heteromer P0DP23; | 4×7PN; | ||||
| Assess | ||||||
| Human KCNQ2(F104A)-CaM-PIP2-CBD complex in state I |
Heteromer P0DP23; | 4×P0T; | ||||
| Assess | ||||||
| Human KCNQ2-CaM complex in the presence of PIP2 |
Heteromer P0DP23; | |||||
| Assess | ||||||
| Human KCNQ2-CaM in complex with CBD |
Heteromer P0DP23; | 8×P0T; | ||||
| Assess | ||||||
| human KCNQ2-CaM in apo state |
Heteromer P0DP25; | |||||
| Assess | ||||||
| human KCNQ2-CaM in complex with ztz240 |
Heteromer P0DP25; | 4×GB9; | ||||
| Assess | ||||||
| human KCNQ2-CaM-Ebio1-S1 complex in the presence of PIP2 |
Heteromer P0DP23; | 4×7Q0; | ||||
| Assess | ||||||
| Human KCNQ2-CaM-HN37 complex in the presence of PIP2 |
Heteromer P0DP23; | 8×9MF; | ||||
| Assess | ||||||
| Solution Structure of CaM/Kv7.2-hAB Complex |
Heteromer P0DP23; | 4×CA; | ||||
| Assess | ||||||
| Solution Structure of CaM/Kv7.2-hAB Complex |
Heteromer P0DP23; | 2×CA; | ||||
| Assess | ||||||
| human KCNQ2 in apo state | homo-4-mer | |||||
| Assess | ||||||
| Human KCNQ2-CaM in complex with HN37 | homo-4-mer | 8×9MF; | ||||
| Assess | ||||||
| human KCNQ2 in complex with retigabine | homo-4-mer | 4×FBX; | ||||
| Assess | ||||||
| human KCNQ2 in complex with ztz240 | homo-4-mer | 4×GB9; | ||||
| Assess | ||||||
3 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8izy.1.A | homo-4-mer | 0.71 | 8×9MF; | 100.00 | ||
| Assess | ||||||
| 8w4u.1.B | monomer | 0.57 | 100.00 | |||
| Assess | ||||||
| 7yo2.1.A | homo-4-mer | 0.52 | 20.69 | |||
| Assess | ||||||
15 SWISS-MODEL models built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 8izy.1.A | homo-4-mer | 0.71 | 8×9MF; | 99.68 | |
| Assess | ||||||
| Isoform 2 | 8w4u.1.B | monomer | 0.59 | 99.68 | ||
| Assess | ||||||
| Isoform 2 | 7yo2.1.A | homo-4-mer | 0.52 | 20.69 | ||
| Assess | ||||||
| Isoform 3 | 8izy.1.A | homo-4-mer | 0.71 | 8×9MF; | 99.18 | |
| Assess | ||||||
| Isoform 3 | 8w4u.1.B | monomer | 0.60 | 99.18 | ||
| Assess | ||||||
| Isoform 3 | 7yo2.1.A | homo-4-mer | 0.52 | 20.69 | ||
| Assess | ||||||
| Isoform 4 | 8izy.1.A | homo-4-mer | 0.71 | 8×9MF; | 99.83 | |
| Assess | ||||||
| Isoform 4 | 8w4u.1.B | monomer | 0.58 | 99.83 | ||
| Assess | ||||||
| Isoform 4 | 7yo2.1.A | homo-4-mer | 0.52 | 20.69 | ||
| Assess | ||||||
| Isoform 5 | 8izy.1.A | homo-4-mer | 0.70 | 4×9MF; | 99.51 | |
| Assess | ||||||
| Isoform 5 | 8w4u.1.B | monomer | 0.57 | 99.51 | ||
| Assess | ||||||
| Isoform 5 | 7yo2.1.A | homo-4-mer | 0.53 | 21.52 | ||
| Assess | ||||||
| Isoform 6 | 8izy.1.A | homo-4-mer | 0.73 | 8×9MF; | 99.67 | |
| Assess | ||||||
| Isoform 6 | 8j05.1.D | monomer | 0.72 | 99.67 | ||
| Assess | ||||||
| Isoform 6 | 7yo2.1.A | homo-4-mer | 0.52 | 20.69 | ||
| Assess | ||||||